Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,189 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancer.
Adam-Artigues A, Arenas EJ, Martínez-Sabadell A, Brasó-Maristany F, Cervera R, Tormo E, Hernando C, Martínez MT, Carbonell-Asins J, Simón S, Poveda J, Moragón S, Zazo S, Martínez D, Rovira A, Burgués O, Rojo F, Albanell J, Bermejo B, Lluch A, Prat A, Arribas J, Eroles P, Cejalvo JM. Adam-Artigues A, et al. Among authors: simon s. Sci Adv. 2022 May 20;8(20):eabk2746. doi: 10.1126/sciadv.abk2746. Epub 2022 May 20. Sci Adv. 2022. PMID: 35594351 Free PMC article.
Circulating miR-30b-5p levels in plasma as a novel potential biomarker for early detection of breast cancer.
Adam-Artigues A, Garrido-Cano I, Simón S, Ortega B, Moragón S, Lameirinhas A, Constâncio V, Salta S, Burgués O, Bermejo B, Henrique R, Lluch A, Jerónimo C, Eroles P, Cejalvo JM. Adam-Artigues A, et al. Among authors: simon s. ESMO Open. 2021 Feb;6(1):100039. doi: 10.1016/j.esmoop.2020.100039. Epub 2021 Jan 18. ESMO Open. 2021. PMID: 33477007 Free PMC article.
Identification of a Two-MicroRNA Signature in Plasma as a Novel Biomarker for Very Early Diagnosis of Breast Cancer.
Adam-Artigues A, Garrido-Cano I, Carbonell-Asins JA, Lameirinhas A, Simón S, Ortega-Morillo B, Martínez MT, Hernando C, Constâncio V, Burgues O, Bermejo B, Henrique R, Lluch A, Jerónimo C, Eroles P, Cejalvo JM. Adam-Artigues A, et al. Among authors: simon s. Cancers (Basel). 2021 Jun 7;13(11):2848. doi: 10.3390/cancers13112848. Cancers (Basel). 2021. PMID: 34200463 Free PMC article.
Ten-year assessment of a cancer fast-track programme to connect primary care with oncology: reducing time from initial symptoms to diagnosis and treatment initiation.
Martínez MT, Montón-Bueno J, Simon S, Ortega B, Moragon S, Roselló S, Insa A, Navarro J, Sanmartín A, Julve A, Buch E, Peña A, Franco J, Martínez-Jabaloyas J, Marco J, Forner MJ, Cano A, Silvestre A, Teruel A, Lluch A, Cervantes A, Chirivella Gonzalez I. Martínez MT, et al. Among authors: simon s. ESMO Open. 2021 Jun;6(3):100148. doi: 10.1016/j.esmoop.2021.100148. Epub 2021 May 11. ESMO Open. 2021. PMID: 33989988 Free PMC article.
Programmed colorectal cancer screening decreases incidence and mortality.
Roselló S, Simón S, Cervantes A. Roselló S, et al. Among authors: simon s. Transl Gastroenterol Hepatol. 2019 Dec 26;4:84. doi: 10.21037/tgh.2019.12.13. eCollection 2019. Transl Gastroenterol Hepatol. 2019. PMID: 32039289 Free PMC article. No abstract available.
NOTCH signalling in ovarian cancer angiogenesis.
Perez-Fidalgo JA, Ortega B, Simon S, Samartzis EP, Boussios S. Perez-Fidalgo JA, et al. Among authors: simon s. Ann Transl Med. 2020 Dec;8(24):1705. doi: 10.21037/atm-20-4497. Ann Transl Med. 2020. PMID: 33490217 Free PMC article. Review.
Role of liquid biopsy for thoracic cancers immunotherapy.
Di Liello R, Cimmino F, Simón S, Giunta EF, De Falco V, Martín-Martorell P. Di Liello R, et al. Among authors: simon s. Explor Target Antitumor Ther. 2020;1(3):183-199. doi: 10.37349/etat.2020.00012. Epub 2020 Jun 29. Explor Target Antitumor Ther. 2020. PMID: 36046196 Free PMC article. Review.
3,189 results